东曜药业(01875.HK)首九个月纯利3,540万人民币 亏转盈

阿斯达克财经
13 Nov 2024

东曜药业-B(01875.HK) 公布9月止九个月财务资料,营业收入8.09亿人民币(下同),按年增加49.3%。录得纯利3,540万元,相较上年同期亏损3,239万元,亏转盈。(de/d)(港股报价延迟最少十五分钟。)

过往派息
公布日期派息事项派息内容
2024/08/13中期业绩无派息
2024/05/10第一季业绩无派息
2024/03/15末期业绩无派息
2023/11/10第三季业绩无派息

AASTOCKS新闻

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10